Huh Yong-Jun
SEC CIK 1931083 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARTV | Artiva Biotherapeutics, Inc. | Dir | 1.64M | $25.00M | — | 3 | 2024-07-22 | 2024-07-22 |
Most active insiders at ARTV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $92.68M | — |
| 2 | GC Corp. | 10% | $16.50M | — |
| 3 | Aslan Fred | Pres, CEO, Dir | — | $1.38M |
| 4 | Banerjee Subhashis | Chief Medical Off | — | $179.5K |
| 5 | Horan Christopher | Chief Tech Ops Off | — | $178.7K |
| 6 | Bush Jennifer | COO, CLO, Secy, Compliance Off | — | $172.8K |
| 7 | Raymon Heather | SVP, Research, Development | — | $27.9K |
| 8 | Krishnamohan Neha | CFO | — | — |
| 9 | Miralles Gines Diego | Pres, Head of R, D | — | — |
| 10 | Huston Thad Allen | CFO | — | — |
Huh Yong-Jun made no open-market trades at ARTV in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-07-22 | 2024-07-22 | ARTV | Artiva Biotherapeutics, Inc. | Huh Yong-Jun | Dir | J - Other | $10.20 | +550.4K | 1.64M | +51% | +$5.61M |
| DMI | 2024-07-22 | 2024-07-22 | ARTV | Artiva Biotherapeutics, Inc. | Huh Yong-Jun | Dir | P - Purchase | $12.00 | +2.08M | 3.31M | +170% | +$25.00M |
| DMI | 2024-07-22 | 2024-07-22 | ARTV | Artiva Biotherapeutics, Inc. | Huh Yong-Jun | Dir | C - Cnv Deriv | — | +1.35M | 587.5K | New | — |
Purchase Sale Sale after option exercise All abbreviations